DBV Technologies S.A. - American Depositary Shares (NQ:DBVT)

16.99 -0.01 (-0.06%)

Streaming Delayed Price Updated: 3:20 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DBV Technologies S.A. - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Nasdaq Down 100 Points; Federal Reserve's Favorite Inflation Gauge Increases More Than Expected ↗

March 28, 2025

Via Benzinga

Topics Economy

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 28, 2025

Via Benzinga

US Stocks Likely To Open Lower, Analysts Warn 'Prolonged Uncertainty Could Hurt Both US And Global Risk Assets' ↗

March 28, 2025

U.S. stock futures fell on Friday after two consecutive days of decline on Wednesday and Thursday. Futures of benchmark indices were lower.

Via Benzinga

DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved

March 27, 2025

From DBV Technologies S.A.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

March 25, 2025

Via Benzinga

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...

March 24, 2025

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress

February 25, 2025

From DBV Technologies S.A.

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 04, 2025

Via Benzinga

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

January 13, 2025

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study

January 08, 2025

From DBV Technologies S.A.

Via GlobeNewswire

DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids ↗

December 12, 2024

DBV Technologies secures FDA guidance for Accelerated Approval of its Viaskin Peanut patch, advancing treatment for toddlers with peanut allergies through pivotal trials.

Via Benzinga

Wall Street Poised To Open Lower A Day After Nasdaq's Record Close Above 20,000: Expert Flags 'Deterioration Under The Surface' As 117 S&P 500 Stocks Hit New Monthly Lows ↗

December 12, 2024

U.S. stock futures declined on Thursday in premarket hours after hitting fresh highs on Wednesday. S&P 500, Dow, Nasdaq 100 & R2K were down.

Via Benzinga

Topics Stocks

Why DBV Technologies Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket ↗

December 12, 2024

Via Benzinga

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old

December 11, 2024

From DBV Technologies S.A.

Via GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024

December 02, 2024

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Announces Plan to Implement ADS Ratio Change

November 11, 2024

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Reports Third Quarter 2024 Financial Results

November 06, 2024

From DBV Technologies S.A.

Via GlobeNewswire

Tesla To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday ↗

October 24, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 24, 2024

Via Benzinga

Why Tesla Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket ↗

October 24, 2024

Via Benzinga

Healthcare and Biotech Stocks to Watch: MODD, CRDL, DBVT, VRAX

October 23, 2024

Via AB Newswire

Topics Intellectual Property

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 23, 2024

Via Benzinga

Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway ↗

October 23, 2024

DBV Technologies progresses with regulatory efforts for its Viaskin Peanut patch in the U.S. and Europe, while financial concerns loom as the company seeks additional funding to continue its...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 23, 2024

Via Benzinga

Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket ↗

October 23, 2024

Via Benzinga

DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe

October 22, 2024

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies to Participate in Upcoming ACAAI 2024 Congress

October 18, 2024

From DBV Technologies S.A.

Via GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024

October 14, 2024

From DBV Technologies S.A.

Via GlobeNewswire

DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial

September 23, 2024

From DBV Technologies S.A.

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.